BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23334129)

  • 1. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
    Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
    Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
    Terasaki F; Fujita SI; Kanzaki Y; Hirose Y; Ishizaka N
    Int Heart J; 2018 May; 59(3):647-651. PubMed ID: 29681578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRI.
    Hotta M; Minamimoto R; Kubota S; Awaya T; Hiroi Y
    Clin Nucl Med; 2018 Jun; 43(6):458-459. PubMed ID: 29538030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and Intraobserver Agreement of
    Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
    J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
    Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
    Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
    Ito K; Miyata Y; Minamimoto R; Kubota K
    Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis].
    Okumura W; Iwasaki T; Ueda T; Seki R; Miyajima A; Hatori T; Sato H; Toyama T; Suzuki T; Matsubara K; Otake H; Aoyagi K; Inoue T; Endo K; Nagai R
    Kaku Igaku; 1999 May; 36(4):341-8. PubMed ID: 10390957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.
    Gormsen LC; Christensen NL; Bendstrup E; Tolbod LP; Nielsen SS
    J Nucl Cardiol; 2013 Dec; 20(6):1108-15. PubMed ID: 24132814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Masuda A; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Hirata K; Nishimura M; Tamaki N
    J Nucl Cardiol; 2016 Apr; 23(2):244-52. PubMed ID: 26243179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.